Pfizer Inc (USD)
PFE
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 36.96 | 37.53 |
| 52-Wk Range | - | - |
| Last Close | 37.50 |
| Mkt Cap (m) | 208,306.27 |
| Dividend yield | 3.95 |
| ISIN | US7170811035 |
| Volume | 14,972,724.00 |
| Exchange Venue | NYS |
Company Profile
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
Key Information
| Price/Earning | 13.39 |
| Price/Book | 3.20 |
| Price/Sales | 4.18 |
| P/CF | 15.08 |
| Rev Growth (3 year avg) | -0.68 |
| EPS Growth (3 year avg) | 0.35 |
| Operating Margin % | 26.90 |
| Net Margin % | 31.45 |
| Return on Equity | 25.72 |
| Debt/Equity | 0.83 |
Documents
Prospectus
| en 20/05/2020 |
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 49,605.00 | 48,851.00 | 52,824.00 | 52,546.00 | 53,647.00 | 51,750.00 |
| Operating Income (m) | 13,499.00 | 12,976.00 | 13,730.00 | 14,107.00 | 15,045.00 | 13,921.00 |
| Net Income (m) | 9,135.00 | 6,960.00 | 7,215.00 | 21,308.00 | 11,153.00 | 16,273.00 |
| Basic EPS | 1.44 | 1.13 | 1.18 | 3.57 | 1.90 | 2.92 |
| Avg. Diluted Shares Outstanding (m) | 6,424.00 | 6,257.00 | 6,159.00 | 6,058.00 | 5,977.00 | 5,675.00 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 57,702.00 | 43,804.00 | 38,949.00 | 41,141.00 | 49,926.00 | 32,803.00 |
| Non Current Assets (m) | 111,573.00 | 123,658.00 | 132,666.00 | 130,654.00 | 109,497.00 | 134,685.00 |
| Total Assets (m) | 169,274.00 | 167,460.00 | 171,615.00 | 171,797.00 | 159,422.00 | 167,489.00 |
| Current Liabilities (m) | 21,631.00 | 29,399.00 | 31,115.00 | 30,427.00 | 31,858.00 | 37,304.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 71,301.00 | 64,720.00 | 59,544.00 | 71,308.00 | 63,407.00 | 63,143.00 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 16,883.00 | 14,512.00 | 15,901.00 | 16,470.00 | 15,827.00 | 12,588.00 |
| Capital Expenditure (m) | -1,583.00 | -1,496.00 | -1,999.00 | -2,217.00 | -2,196.00 | -2,594.00 |
Figures are quoted in USD unless stated otherwise
-
No change
$
37.50
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.